A. Narayanan

Efficacy of convalescent plasma therapy in the patient with COVID-19: a randomised control trial (COPLA-II trial)

S. Sarin, C. Bihari, N. Trehanpati, 2022, BMJ Open.

Efficacy of Convalescent Plasma Therapy compared to Fresh Frozen Plasma in Severely ill COVID-19 Patients: A Pilot Randomized Controlled Trial

R. Maiwall, R. Singh, P. Yadav, 2020, medRxiv.

Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis

Arvind Singh Tomar, S. Sarin, R. Maiwall, 2021, JHEP Reports.

Comparison of safety and efficacy of convalescent plasma with fresh frozen plasma in severe covid-19 patients.

S. Sarin, Kamini Gupta, E. Gupta, 2022, Anais da Academia Brasileira de Ciencias.

Running title: TREATMENT OF COVID-19 BY CONVALESCENT PLASMA Academy Section: HEALTH SCIENCES

S. Sarin, Kamini Gupta, Nirupama, 2022 .

Elevated Plasma Levels of ICAM1 Predict Mortality in COVID-19 and Sepsis Patients with Liver Cirrhosis

Arvind Singh Tomar, S. Sarin, R. Maiwall, 2020, SSRN Electronic Journal.